Pharmacy Times

JUNE 12, 2025

Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” with the objective of lowering drug prices, namely on branded drug products, for American consumers. How Does Drug Pricing in the US Compare With Other Countries?

Pharmacy Technician 26

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals 26

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out?

Hospitals 52

Hospitals Insurance Coverage and Processing Packaging Communication 52

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Drug Development Drug Pricing Biosimilars 52

Pharmaceutical Technology

JULY 10, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. The partnership will enhance the availability of the affordable biosimilar on a global scale. Stay proactive with real-time data and expert analysis.

Biosimilars 52

Biosimilars Packaging Hospitals Communication 52

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU). Clinical trials have demonstrated that both biosimilars match the reference product’s safety, quality and efficacy standards.

Biosimilars 52

Biosimilars Chemotherapy Packaging Communication 52

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Adverse Reactions Communication Hospitals 52

Pharmaceutical Technology

JULY 11, 2025

How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Bevacizumab Biosimilar in Endometrial Cancer Reports LOA and PTSR Model - Iparomlimab + Tuvonralimab in Nasopharyngeal C. Data Insights The gold standard of business intelligence.

Packaging 52

Packaging Hospitals Biosimilars Communication 52

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out?

Labelling 52

Labelling Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 27, 2025

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest does – is $1,350 in the US, whereas the same dose in the UK costs £175.80

Drug Pricing 59

Drug Pricing Compounding Packaging Online Pharmacies 59

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108

Vaccines Drug Pricing Documentation Biosimilars 108

BioPharma Dive

JULY 22, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief // Vaccines Sanofi to acquire vaccine biotech in billion-dollar deal The French pharma will pay $1.15 headquarters in Bridgewater, New Jersey.

Vaccines 57

Vaccines Drug Pricing Labelling Biosimilars 57

Pharmaceutical Technology

DECEMBER 20, 2022

This downturn in market cap was attributed to a decline in the demand for Covid-19 vaccines and therapies. The growing competition from generic drugs presents challenges for the top 20 players placing pressure on drug prices. billion for Q3, according to GlobalData’s Drugs Database. trillion in Q2 2022 to $3.14

Vaccines 52

Vaccines Diabetes Drug Pricing Biosimilars 52

BioPharma Dive

JULY 21, 2025

After the fierce competition between Humira (adalimumab) biosimilars, manufacturers are keeping a close eye on adoption dynamics for biosimilars of Johnson & Johnson’s autoimmune drug, Stelara (ustekinumab). What is the impact of vertical integration, the IRA and other factors on biosimilar adoption?

Biosimilars 52

Biosimilars Labelling Drug Pricing Vaccines 52

pharmaphorum

SEPTEMBER 8, 2020

In my role at Sandoz, I work with teams that are passionately trying to drive healthcare sustainability through the increased use of high-quality biosimilars. In the US, biologic medicines represent 2% of medicine budget volume yet represent 37% of net drug spending. 7 Delivering on the Potential of Biosimilar Medicines.

Biosimilars 99

Biosimilars Drug Pricing Chemotherapy Vaccines 99

FDA Law Blog: Biosimilars

DECEMBER 3, 2023

The manufacturer’s agreement must cover all its labeler codes that contain an applicable drug or a selected drug. The primary manufacturer of a selected drug may also request CMS to terminate its agreement if they are unwilling to participate in the Medicare Drug Price Negotiation.

Labelling 105

Labelling Drug Pricing Compounding Payment Processing 105

Pharmaceutical Technology

SEPTEMBER 26, 2022

The company told GlobalData PharmSource: “The biosimilar facilities in Austria and Slovenia would continue to manufacture biosimilars for Sandoz under a contractual agreement with Novartis. These highlight the parent company’s focus on innovative and high-value drug development.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

Drug Channels

FEBRUARY 22, 2022

On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2022 edition at special discounted prices.

Specialty Pharmacies 96

Specialty Pharmacies Drug Pricing Biosimilars Vaccines 96

Pharma in Brief

JANUARY 10, 2024

Expected highlights for 2024 include a final PTA regime, more details on PMPRB drug pricing guidelines and national pharmacare, and fall-out from the US mass drug importation program targeting Canadian medicines. billion over three years to help increase drug access and affordability (see here ).The Rare disease strategy.

Drug Pricing 52

Drug Pricing Documentation Biosimilars Vaccines 52

FDA Law Blog: Biosimilars

JUNE 2, 2023

Absent from the statute is any requirement to report information on manufacturer costs and price setting. Nevertheless, riding on the wave of drug price transparency legislation in several states and similar legislative proposals in Congress, CMS is proposing to expand the MDRP into the realm of drug price transparency reporting.

Labelling 59

Labelling Vaccines Drug Pricing Immunity 59

Safe Biologics

APRIL 25, 2023

By Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines (ASBM) ASBM recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed Medicare Drug Price Negotiation Plan. Price controls, as proposed in the negotiation plan, may jeopardize this success.

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

Safe Biologics

APRIL 25, 2023

By Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines (ASBM) ASBM recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed Medicare Drug Price Negotiation Plan. Price controls, as proposed in the negotiation plan, may jeopardize this success.

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

Pharmaceutical Technology

FEBRUARY 8, 2023

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion between Dec 31, 2021 and Dec 31, 2022, owing to expansion in its vaccine and oncology portfolio.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 78

Safe Biologics

SEPTEMBER 11, 2023

September 11, 2023 The Centers for Medicare & Medicaid Services (CMS) recently announced the first 10 drugs selected under its Medicare drug price “negotiation” plan, authorized by the Inflation Reduction Act (IRA) signed in to law last year. 1] 90% of new cancer drugs are available in the U.S.

Drug Pricing 150

Drug Pricing Biosimilars Drug Development Vaccines 150

Express Pharma

APRIL 1, 2025

While this strategic shift supports supply chain resilience, it may also elevate production costs and drug pricesraising concerns around affordability as emerging markets pursue regulatory reforms to boost access to biosimilars and biologics, says GlobalData.

Biosimilars 66

Biosimilars Drug Pricing Vaccines Pharmaceutical Companies 66

pharmaphorum

JANUARY 22, 2021

We don’t believe there will be draconian price cuts, for the same reason. The Biden administration could put additional scrutiny on drug prices, but more drastic measures, such as allowing Medicare to negotiate with pharma companies directly, are still unlikely.”. ” Science first.

Drug Pricing 63

Drug Pricing Packaging Biosimilars Pharmaceutical Companies 63

Express Pharma

FEBRUARY 10, 2025

India trends: The power of AI and data analytics is ushering generative AI, along with AI and ML, into the Indian biopharma industry, contributing to areas such as disease understanding and vaccine development. India is streamlining processes for faster approvals of biologics and biosimilars, aiming to speed up access to effective therapies.

Documentation 100

Documentation Drug Pricing Biosimilars Labelling 100

Safe Biologics

MARCH 10, 2025

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. Read the full statement here.

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130

STAT

MAY 21, 2025

Department of Health and Human Services will aim to negotiate drug prices down to the lowest prices paid by peer nations, and the pricing targets will apply to brand-name drugs that do not face competition from generics or biosimilars. Food and Drug Administration , Reuters notes.

Drug Pricing 152

Drug Pricing Vaccines Biosimilars 152